Hemda Schmilovitz-Weiss
Tel Aviv University
Internal medicineEndocrinologySurgeryPathologyRetrospective cohort studyImmunologyBreath testHepatitis C virusHelicobacter pyloriLiver diseaseCirrhosisFatty liverLiver transplantationFibrosisMicrosurgeryPopulationTransplantationHepatic fibrosisIn patientMedicineGastroenterology
Publications 60
#1Rachel Gingold-Belfer (TAU: Tel Aviv University)H-Index: 5
#2Yaron Niv (National Patient Safety Foundation)H-Index: 1
Last. Doron Boltin (TAU: Tel Aviv University)H-Index: 13
view all 0 authors...
BACKGROUND AND AIM Empirical therapy for Helicobacter pylori infection is limited by increasing antibiotic resistance and suboptimal eradication rates. Studies of the relative effectiveness of susceptibility-guided therapy have produced conflicting results. We performed a systematic review and meta-analysis of randomized controlled trials (RCTs) to determine whether susceptibility-guided therapy is superior to empirical therapy for H. pylori infection. METHODS We searched articles listed in PubM...
#1Hemda Schmilovitz-Weiss (TAU: Tel Aviv University)H-Index: 14
#2Doron Boltin (TAU: Tel Aviv University)H-Index: 13
Last. Hanna Bernstine (TAU: Tel Aviv University)H-Index: 11
view all 13 authors...
Abstract Aim of the study To compare [¹¹C] choline PET/CT findings between patients with cirrhosis and normal liver controls. Methods Included 11 patients with cirrhosis and 14 controls. All underwent a dynamic [11C] choline PET/CT. The maximal standard uptake values (SUVmax), the area under the curve (AUC) and kinetic parameters (K1 and K2), clinical and laboratory data, were compared between groups. Results Patients mean age was 68.4 ± 10.7 and controls, 69.7 ± 7.3 years. Mean SUVmax was highe...
#1Hemda Schmilovitz-Weiss (Rabin Medical Center)H-Index: 14
#2Rachel Gingold-Belfer (TAU: Tel Aviv University)H-Index: 5
Last. Avraham Weiss (Rabin Medical Center)H-Index: 21
view all 11 authors...
Data on cardiovascular outcomes in elderly using proton pump inhibitors (PPI) are scant. We aimed to test the association between PPI use and the occurrence of first-time ischemic stroke (FTIS) among elderly. The electronic database of a centrally located district branch of a large health maintenance organization in Israel was retrospectively screened (2002-2016) for community-dwelling individuals (≥65-95 years) for demographics and co-morbidities. Follow-up was until FTIS, death or end of study...
#1Ram Dickman (Rabin Medical Center)H-Index: 21
#2Sigal LevyH-Index: 8
Last. Rachel Gingold-Belfer (Rabin Medical Center)H-Index: 8
view all 11 authors...
#1Noam Peleg (Rabin Medical Center)H-Index: 8
#2Hemda Schmilovitz-Weiss (Rabin Medical Center)H-Index: 14
Last. Boris Sapoznikov (TAU: Tel Aviv University)H-Index: 1
view all 6 authors...
Background Patient’s with Barrett’s esophagus (BE) are at risk of progression to esophageal adenocarcinoma (EAC). Neutrophil to lymphocyte ratio (NLR) was found to be a predictor of poor prognosis in patients with EAC; however, its performance in premalignant esophageal lesions is vague. We aimed to evaluate the utility of NLR as a predictor of histologic progression in patients with BE. Methods A prospective cohort of patients with proven BE in a tertiary referral center was retrospectively ana...
#1Noam PelegH-Index: 8
Last. Boris SapoznikovH-Index: 5
view all 5 authors...
#1Doron BoltinH-Index: 13
#2Zohar LeviH-Index: 28
Last. Shlomo Birkenfeld (TAU: Tel Aviv University)H-Index: 3
view all 8 authors...
GOALS: The goal of this study was to examine the impact of prior treatment with a nitroimidazole antibiotic on the success of Helicobacter pylori treatment. BACKGROUND: Prior nitroimidazole exposure may increase the likelihood of nitroimidazole-resistant H. pylori. Current H. pylori treatment guidelines recommend that, in the absence of susceptibility testing, patients with prior nitroimidazole exposure should not be treated with a nitroimidazole antibiotic. Data to support this recommendation a...
2 CitationsSource
#1Doron Boltin (Rabin Medical Center)H-Index: 13
#2Zohar Levi (Rabin Medical Center)H-Index: 28
Last. Yaron NivH-Index: 62
view all 9 authors...
INTRODUCTION: Suppression of gastric acid secretion with proton-pump inhibitors (PPI) is an integral part of the treatment of Helicobacter pylori infection. Esomeprazole has been shown to be superior to other PPIs when used in the context of triple therapy; however, comparative data for PPI efficacy in quadruple therapy are lacking. Current guidelines recommend H. pylori eradication with quadruple therapy in areas with high clarithromycin resistance. OBJECTIVE: To determine whether esomeprazole ...
3 CitationsSource